Immune Therapy Holdings (Sweden)
Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis treatment for immune mediated inflammatory diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Immune Therapy Holdings (Sweden), Sweden, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
83%
Total
Publications
63
Total Open
Publications
52
Total
Citations
714
Open Access
Percentage
83%
Total
Publications
63
Total Open
Publications
52
Total
Citations
714
Breakdown
Publisher Open
35%
Both
38%
Other Platform Open
10%
Closed
17%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
14
Hybrid 39%
18
No Guarantees 30%
14
Other Platform Open
Domain 80%
24
Institution 13%
4
Other Internet 10%
3
Preprint 7%
2
Public 3%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 24 |
Europe PMC | Domain | 6 |
University of Szeged - SZTE Publicatio Repozitórium - SZTE - Repository of Publications | Institution | 2 |
University of Bristol - Bristol Research | Institution | 2 |
KTH Royal Institute of Technology - KTH Publication Database DiVA | Other Internet | 2 |
University of Surrey - Surrey Open Research repository | Institution | 1 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 1 |
University of Oxford - Oxford Academic Notes & Queries | Institution | 1 |
University of Oslo - Duo Research Archive | Institution | 1 |
University of Geneva - Archive ouverte UNIGE | Institution | 1 |